corporate-law is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Abbott Laboratories, the most common co-covered peer. Sturgis, Michigan plant appears in 1 tracked Legal story from September 14, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Sturgis, Michigan plant
corporate-law is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Abbott Laboratories, the most common co-covered peer. Sturgis, Michigan plant appears in 1 tracked Legal story from September 14, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Sturgis, Michigan plant. Shared-story counts are live from our verified record — not editorial picks.
Abbott agrees to pay $385 million to resolve Justice Department claims and lawsuits by relators and state Attorneys General; Abbott says the deal is not a finding of fault or liability.
Sturgis plant reopens
Abbott reopens the largest U.S. baby formula plant by June 2022 after the shutdown.
Sturgis plant closure and recall
Abbott closes the Sturgis, Michigan facility after the FDA begins an investigation; recall covers powdered infant formula brands including Similac.
Federal emergency response
The Biden administration eases import rules, airlifts formula from Europe, and invokes federal emergency rules to prioritize U.S. production during the formula shortage.
Abbott will pay $385M to resolve DOJ, relator, and state AG claims tied to the Sturgis formula shutdown while denying liability. The case shows how a single plant failure can create multi-front federal, qui tam, and state exposure.